- Caplacizumab-yhdp injection is used to treat acquired thrombotic thrombocytopenic purpura (aTTP; a disorder in which the body ... combination with plasma exchange therapy and immunosuppressant medications. Caplacizumab-yhdp is in a class of medications called antithrombotic ...
- NLM Digital Collections - FDA oversightPublication: [Toronto, Ontario] : Thomson Reuters, 23-December-2019... On February 6, 2019, the FDA approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination ...
5 results